Associated Papers
Finding driver mutations in cancer: Elucidating the role of background mutational processes.
Brown AL et al.
Plos Computational Biology, 2019
31034466 (PubMed )
Supplement: pcbi.1006981.s010.xlsx › final_benchmark
MITF Modulates Therapeutic Resistance through EGFR Signaling.
Ji Z et al.
The Journal of Investigative Dermatology, 2015
ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
Bill A et al.
Oncotarget, 2015
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.
Cho J et al.
Cancer Research, 2013
Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
Whitsett TG et al.
The American Journal of Pathology, 2012
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.
Greulich H et al.
Plos Medicine, 2005
Select a paper to view details